Roche’s Tecentriq Wins FDA Nod for Label Expansion in Bladder Cancer |
Roche RHHBY announced that the FDA has approved a label expansion for Tecentriq (atezolizumab) and Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs)…
Browsing Tag